题目：Correlation of genetic and cardiovascular risk markers with blood telomere length–understanding role of telomere in cardiovascular disease
报告人：Dr. WANG Xueying,
Assistant Professor and Principal Investigator at Department of Biochemistry,
NUS, Singapore
时间： 2013年5月20日 上午 10：00-11：00
地点： 闵行校区， 生物药学楼1号楼 (大红楼) 105室
请有兴趣的同学准时参加。
Bibliography of the speaker:
Dr. Xueying Wang was one of the first scholars awarded by the Economic Developmental Board of Singapore (EDB)-Glaxo Wellcome (GSK) for the pursuit of a degree in life sciences. She graduated from the University of Toronto and then went on to pursue her Ph.D. at the Institute of Molecular and Cell Biology (IMCB), Singapore, where she conducted research in the areas of mouse developmental biology and signaling transduction under the mentorship from Prof. Baojie Li. In 2006, Dr. Wang joined Prof. Elizabeth Blackburn’s lab in the University of California, San Francisco (UCSF) where she held a Susan Komen Breast Cancer Foundation fellowship. During her stint at UCSF, she has been a highly enterprising and collaborative researcher. Her research centres on telomeres, the protective ends of the chromosomes, and on telomerase, the enzyme, which Prof. Blackburn originally discovered. Together with Prof. John Sedat, they explored a live cell dynamic approach to telomere regulation. The topic of how chromosomes are protected by telomeres and the enzyme telomerase has won Prof. Blackburn the Nobel Prize for Physiology or Medicine in 2009. Dr. Wang is currently developing a novel anti-cancer therapy based on telomerase inhibitors and aims to decipher the mechanisms of telomere attrition-induced body dysfunctions using both human disease samples and mouse models to provide new therapeutics for telomerase-regulated human diseases. Dr. Wang has won many awards including the AACR-MERCK award and was appointed the Principal Investigator of her lab in the National University of Singapore in Dec 2008 to further develop the fundamental biological research into this promising new avenue of telomerase for the potential treatment of cancer and aging disorders.
